TIQRX
Price
$42.61
Change
+$0.44 (+1.04%)
Updated
Jun 6 closing price
Net Assets
50.81B
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

TIQRX vs VITSX

Header iconTIQRX vs VITSX Comparison
Open Charts TIQRX vs VITSXBanner chart's image
Nuveen Equity Index R
Price$42.61
Change+$0.44 (+1.04%)
VolumeN/A
Net Assets50.81B
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
TIQRX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TIQRX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TIQRX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. TIQRX (50.8B). VITSX pays higher dividends than TIQRX: VITSX (1.29) vs TIQRX (1.04). TIQRX was incepted earlier than VITSX: TIQRX (19 years) vs VITSX (28 years). TIQRX (0.30) is less costly to investors than VITSX (0.03). TIQRX is a more actively managed with annual turnover of: 3.00 vs. VITSX (2.00). TIQRX has a lower initial minimum investment than VITSX: TIQRX (0) vs VITSX (5000000). TIQRX annual gain was more profitable for investors over the last year : 11.79 vs. VITSX (10.97). TIQRX return over 5 years is better than : 87.50 vs. VITSX (80.96).
TIQRXVITSXTIQRX / VITSX
Total Expense Ratio0.300.031,000%
Annual Report Gross Expense Ratio0.300.031,000%
Fund Existence19 years28 years-
Gain YTD1.1270.833135%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets50.8B1.82T3%
Annual Yield % from dividends1.041.2980%
Returns for 1 year11.7910.97108%
Returns for 3 years42.9940.35107%
Returns for 5 years87.5080.96108%
Returns for 10 years179.21180.4999%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.